Beyond lipid-lowering: effects of statins on endothelial nitric oxide. - Wikidata - awgldk - TriplyDB

Beyond lipid-lowering: effects of statins on endothelial nitric oxide.

Beyond lipid-lowering: effects of statins on endothelial nitric oxide.

http://www.wikidata.org/entity/Q35084723

about

Effect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study.Statin-Induced Increases in Atrophy Gene Expression Occur Independently of Changes in PGC1α Protein and Mitochondrial Content Multifunctional drugs for head injury Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study.2,3,7,8-TCDD exposure, endothelial dysfunction and impaired microvascular reactivity.Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1 Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment.Simvastatin augments the efficacy of therapeutic angiogenesis induced by bone marrow-derived mesenchymal stem cells in a murine model of hindlimb ischemia.Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protection Hypercholesterolemia and microvascular dysfunction: interventional strategies.Distribution of endogenous farnesyl pyrophosphate and four species of lysophosphatidic acid in rodent brain.Adventures in vascular biology: a tale of two mediators.Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage.Therapeutic levels of the hydroxmethylglutaryl-coenzyme A reductase inhibitor lovastatin activate ras signaling via phospholipase D2.Heat shock proteins modulate keloid formation.Granulocyte-CSF induced inflammation-associated cardiac thrombosis in iron loading mouse heart and can be attenuated by statin therapy.High doses of simvastatin upregulate dopamine D1 and D2 receptor expression in the rat prefrontal cortex: possible involvement of endothelial nitric oxide synthase.Prevention of arterial stiffening by using low-dose atorvastatin in diabetes is associated with decreased malondialdehyde.Atorvastatin inhibits inflammatory hypernociception.Rho GTPases as therapeutic targets for the treatment of inflammatory diseases.The discovery of nitric oxide and its role in vascular biology.Cytoadherence and severe malaria.Biomarkers and surrogate endpoints in kidney disease.Atorvastatin does not protect against ischemia-reperfusion damage in cholestatic rat livers Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?Statins and the vascular endothelial inflammatory response A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction.Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein In situ eNOS/NO up-regulation-a simple and effective therapeutic strategy for diabetic skin ulcer.Lovastatin exerts protective effects on endothelial cells via upregulation of PTK2B.Long-term benefits after treatment of traumatic brain injury with simvastatin in rats.Statins as adjunctive therapy in the management of hypertension.Potential role of statins on wound healing: review of the literature.Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury.ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs--threshold doses for tissue reactions in a radiation protection context.Advances in treatment strategies for ischemia reperfusion injury.Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial.Biodegradable Polymers Influence the Effect of Atorvastatin on Human Coronary Artery Cells The Arginine/ADMA Ratio Is Related to the Prevention of Atherosclerotic Plaques in Hypercholesterolemic Rabbits When Giving a Combined Therapy with Atorvastatine and Arginine.

P2860

Q24531203-527C0305-A995-482C-8835-157C417E14DF Q27305332-E27ABF3A-90BC-4B12-BA68-1754E7A8C38F Q30371428-B2D427D1-C775-4613-AD09-D1D58B383528 Q31120569-6D9346B0-952D-4102-BA01-3F35F6A993E8 Q33305054-88BAC58B-4644-4C08-8393-7E46C2EAF407 Q33358641-7BF5F45C-1161-471D-81F3-5AF49BA3EB03 Q33571813-171129F6-6D53-4DE8-A681-E268CF84F2C2 Q33746493-2CE354C1-CDA1-4DC7-B8D7-72D2580E99F7 Q33892777-4638FC57-F021-4775-A11E-5A01F8DBE882 Q34088803-D208B450-3295-4896-80F8-773C027923F2 Q34375542-5B2B1AD3-2D48-4ACA-95A3-E16F0D3AAF69 Q34378141-6916EE4C-B8EF-4300-86AF-0CFC2C21B9F6 Q34515584-ED002B5E-606E-464C-BF16-C9FD70FB4658 Q34669052-FAC7F52C-EA7A-4007-8FB0-4F29911D9DD8 Q34742771-D2F04A4A-2A63-4A29-B864-B1DA9AAB6F6E Q34911441-A0DE22D2-B3FA-4E4C-BCB6-9299FF702014 Q34984092-57052EB4-ADF6-46FB-89E3-ABDC245773B2 Q35048736-1B52CE50-49A9-4DDD-A560-EEBED1A3AA12 Q35111240-AF274B84-D549-44F2-BDA7-6B55A8A66249 Q35119935-272DC7C6-0D9E-4B16-BF98-560A6ED3E2B9 Q35537884-8CC80838-2889-4BA7-ACB1-935360C93EF5 Q35566587-0C77A9B2-31E3-4AD6-BD8C-967F22C4A14F Q36202059-B4E38937-DE27-47E0-AE3D-D3078F5D1BC3 Q36284659-6212C325-21DE-4312-A13D-5E48DA5F353B Q36343844-13D1EF18-C84C-4832-B40E-EB0E60B9C4D5 Q36577189-C9D2B61B-CF39-4810-84B9-E028D4B7B986 Q36695979-5C92CA33-A273-4D1E-9FEF-0078527C82BA Q36697677-C582F824-E4CA-4726-826B-5EA54E2757A6 Q37078834-340A1937-DA80-4E9E-8F6F-11077F780953 Q37121695-BDE1F2FA-7AE4-465F-9F97-3F9E92078D84 Q37204781-D3675B68-65A3-4E35-AAC9-7275841B4BCF Q37341566-0A7C5B14-5B83-4E6A-967A-986A2AA1F001 Q37761679-C05E5F16-2BCF-428A-ABA5-38FD463ED715 Q37952338-ADD5F285-85D8-4889-9F24-70E983BA27E7 Q38030379-8DF6A71A-5E35-4D06-AD1A-BFCD65F2E161 Q38038330-2406BBA0-1EBC-423F-8723-3326A27BC357 Q38690399-2B0AFB24-3E0D-44E1-A63D-A33BC97610C5 Q38859913-457212B3-777D-4B62-9A4E-606AFF07A41E Q38861711-923772D8-6E30-4BE3-BD2A-8BEF22C50AFE Q41456914-7749EFCC-C8B9-45B5-942E-4695878005F2

P2860

Beyond lipid-lowering: effects of statins on endothelial nitric oxide.

http://www.wikidata.org/entity/Q35084723

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Beyond lipid-lowering: effects of statins on endothelial nitric oxide.

@ast

Beyond lipid-lowering: effects of statins on endothelial nitric oxide.

@en

type

label

Beyond lipid-lowering: effects of statins on endothelial nitric oxide.

@ast

Beyond lipid-lowering: effects of statins on endothelial nitric oxide.

@en

prefLabel

Beyond lipid-lowering: effects of statins on endothelial nitric oxide.

@ast

Beyond lipid-lowering: effects of statins on endothelial nitric oxide.

@en

P1433

Q35084723-471600D6-B5E8-46BB-9E13-736D6C4E6199

P1476

Q35084723-814F293A-0F09-4AA2-9132-0AE1EB606C35

P2093

Q35084723-BFFB3205-931A-4457-B149-975D164B7933

P2860

Q35084723-025CD62C-78C5-4692-AFC9-36BA3BE17B59

Q35084723-02DA636F-A19F-4F8F-9D07-DB0A3AEABEDF

Q35084723-04C3CA70-6433-40B8-AD7A-2FFBE72B4097

Q35084723-0DE15207-4A05-49C0-A0BA-2D2AB2C441B1

Q35084723-102A7976-B904-47B7-A53B-8CADAB285CE4

Q35084723-1698EBD5-6983-45AC-B0F8-CA1CBED37A01

Q35084723-19D1E460-3E1A-45F6-B742-71A760B24E9B

Q35084723-203394C5-F3C9-4610-8887-60B9C22E58D6

Q35084723-2066FE93-CE09-4883-AE13-3E8E46831F73

Q35084723-23A860E0-A5CD-45C7-8DD7-6B1A7871A8EB

P2888

Q35084723-FF1DCA12-DDE9-4951-B316-03490155C17D

P304

Q35084723-B3DD09C6-DF97-441F-A6A5-0C116561165C

P31

Q35084723-8272D2C7-5005-4E8E-8CF3-3D9C5AD05919

P356

Q35084723-419FDE5D-A2FA-4086-B1D2-290CB4CFE081

P433

Q35084723-6ABB498E-1AC2-45DC-9B85-D0683A87B19C

P478

Q35084723-4768349E-09C0-465B-8DA2-2A08D08F5C6D

P577

Q35084723-C2FB6394-4D9A-4805-B38E-CC94F61399C9

P698

Q35084723-82EB0093-3A23-479E-87E1-303CCB20398D

P921

Q35084723-856D3E28-DA55-4F7D-9336-2532450B365F

P356

S00228-002-0556-0

P1433

European Journal of Clinical Pharmacology

P1476

Beyond lipid-lowering: effects of statins on endothelial nitric oxide.

@en

P2093

Ulrich Laufs

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

Structural mechanism for statin inhibition of HMG-CoA reductase

Rho GTPases and the actin cytoskeleton

Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase

A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

Direct effects of statins on cells primarily involved in atherosclerosis

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Inflammation and atherosclerosis

P2888

s00228-002-0556-0

P304

719-731

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00228-002-0556-0

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12634978

http://www.w3.org/2001/XMLSchema#string

P921